{
    "2018-08-13": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Mylan Launches First Adcirca Generic, Stock Moves Up",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Adcirca",
                        "generic",
                        "stock moves up"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Novo Nordisk’s Long-Acting Insulins: A Performance Overview",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "long-acting insulins",
                        "performance overview"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Can Victoza Continue to Boost Novo Nordisk’s Revenue Growth?",
                "features": {
                    "keywords": [
                        "Victoza",
                        "Novo Nordisk",
                        "revenue growth"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings",
                "features": {
                    "keywords": [
                        "Lilly",
                        "LLY",
                        "Q2 earnings",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Novo Nordisk: A Financial Overview after the First Half of 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "financial overview",
                        "first half 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-14",
                "original_text": "Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings",
                "features": {
                    "keywords": [
                        "Lilly",
                        "LLY",
                        "Q2 earnings",
                        "stock up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-14",
                "original_text": "Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 14, 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "ex-dividend date",
                        "August 14"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}